Literature DB >> 9176121

Mechanisms of complement resistance induced by non-lethal complement attack and by growth arrest.

K J Marchbank1, C W van den Berg, B P Morgan.   

Abstract

Non-lethal complement (C) attack on K562 cells has been shown to induce a transient resistance to lethal amounts of C. We have previously shown that incubation of K562 with phorbol 12-myristate 13-acetate (PMA) caused an increase in both CD59 expression and resistance to C killing and we were interested to examine whether non-lethal C attack caused a similar effect. We here demonstrate that expression of the C inhibitors decay-accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 was unaltered on K562 after non-lethal C attack and that neutralization of these inhibitors with specific blocking antibodies did not reverse the induced resistance. In an effort to understand the mechanisms of resistance we searched for other conditions that might induce C resistance in K562 cells. Growth-arrested cells showed a similar degree of resistance to C killing. The levels of DAF and MCP on these cells were unaltered whereas expression of CD59 was markedly reduced. Non-lethal C attack on these growth-arrested cells induced a further increase in resistance to C killing, suggesting that the mechanisms of resistance were not identical. Indeed, resistance of non-lethally attacked cells was completely lost within 8 hr of attack whereas resistance of growth-arrested cells was detectable for up to 48 hr after returning to cell cycle. These data demonstrate that C resistance induced by two distinct strategies is not mediated by the known membrane C inhibitors. Resistance may be a result of the expression of a novel inhibitor or due to metabolic depletion, a likely common consequence of non-lethal C attack and induction of growth arrest, implying that cells take an active role in C-mediated killing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176121      PMCID: PMC1456691          DOI: 10.1046/j.1365-2567.1997.00197.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  The action of antibody and complement on mammalian cells.

Authors:  H GREEN; B GOLDBERG
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

2.  Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis.

Authors:  Y Reiter; A Ciobotariu; J Jones; B P Morgan; Z Fishelson
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

Review 3.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP).

Authors:  Y Reiter; Z Fishelson
Journal:  Mol Immunol       Date:  1992-06       Impact factor: 4.407

5.  The use of conventional and zonal centrifugation to study the life cycle of mammalian cells. Phospholipid and macromolecular synthesis in neoplastic mast cells.

Authors:  A M Warmsley; C A Pasternak
Journal:  Biochem J       Date:  1970-09       Impact factor: 3.857

6.  Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack.

Authors:  K J Marchbank; B P Morgan; C W van den Berg
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

7.  Phospholipid synthesis in HeLa cells exposed to immunoglobulin G and complement.

Authors:  F Güttler
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

8.  Cross-linking of CD59 and of other glycosyl phosphatidylinositol-anchored molecules on neutrophils triggers cell activation via tyrosine kinase.

Authors:  B P Morgan; C W van den Berg; E V Davies; M B Hallett; V Horejsi
Journal:  Eur J Immunol       Date:  1993-11       Impact factor: 5.532

9.  In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal.

Authors:  S W Sherwood; A L Kung; J Roitelman; R D Simoni; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Dissociation of nuclear and cytoplasmic cell cycle progression by drugs employed in cell synchronization.

Authors:  L Urbani; S W Sherwood; R T Schimke
Journal:  Exp Cell Res       Date:  1995-07       Impact factor: 3.905

View more
  4 in total

1.  Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.

Authors:  N Donin; K Jurianz; L Ziporen; S Schultz; M Kirschfink; Z Fishelson
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 2.  Accommodation of grafts: implications for health and disease.

Authors:  Amy H Tang; Jeffrey L Platt
Journal:  Hum Immunol       Date:  2007-05-15       Impact factor: 2.850

3.  Down-regulation of CD55 and CD46 expression by anti-sense phosphorothioate oligonucleotides (S-ODNs) sensitizes tumour cells to complement attack.

Authors:  S Zell; N Geis; R Rutz; S Schultz; T Giese; M Kirschfink
Journal:  Clin Exp Immunol       Date:  2007-09-28       Impact factor: 4.330

4.  Complement susceptibility in glutamine deprived breast cancer cells.

Authors:  Bradley S Ellison; Mary Kb Zanin; Robert J Boackle
Journal:  Cell Div       Date:  2007-07-11       Impact factor: 5.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.